No detectable increase in pregnancy risks after GLP-1 exposure around conception, largest review to date finds
Exposure to GLP-1 weight-loss and diabetes drugs around conception is not linked to a clearly detectable increase in adverse outcomes for mothers or babies, according to the largest study of its kind, involving more than ...
Oct 5, 2026
0
11









